Posts Tagged ‘PT2385’

Peloton Therapeutics Completes Series D Financing

Posted by Nealie Sanchez

Peloton Therapeutics, a clinical-stage biotechnology company, announced Thursday that it completed its $52.4 million Series D financing round.

The round included new investor Foresite Capital Management and participation from all its existing investors, including Remeditex LLC, The Column Group, Tichenor …